Suppr超能文献

重复选择性激光小梁成形术。

Repeat selective laser trabeculoplasty.

作者信息

Hong Bryan Kun, Winer Jeffrey C, Martone James F, Wand Martin, Altman Bruce, Shields Bruce

机构信息

Yale University School of Medicine, New Haven, CT, USA.

出版信息

J Glaucoma. 2009 Mar;18(3):180-3. doi: 10.1097/IJG.0b013e31817eee0b.

Abstract

PURPOSE

To evaluate the efficacy of repeat 360-degree selective laser trabeculoplasty (SLT) in glaucoma patients with prior successful 360-degree SLT.

DESIGN

Retrospective chart review.

METHODS

Forty-four eyes of 35 patients, > or =18 years of age, with open-angle glaucoma (primary open-angle, pseudoexfoliation, or pigmentary glaucoma), uncontrolled on maximum tolerable medical therapy, underwent an initial 360-degree SLT (SLT1), which was successful for > or =6 months, but eventually lost efficacy and was followed by a repeat 360-degree SLT (SLT2). Patients with prior argon laser trabeculoplasty or other glaucoma surgery, before or during the study period, were excluded. Intraocular pressure (IOP) measurements were recorded before each procedure and 1 to 4 weeks, 1 to 3 months, and 5 to 8 months posttreatment and 15 to 21 weeks after the initial SLT.

RESULTS

Reduction in IOP after SLT1 and SLT2 was significantly less with repeat treatment at 1 to 3 months, with average decreases of -5.0 and -2.9 mm Hg, respectively (P=0.01), but there were no statistically significant differences between treatments at the other equivalent time points. Using a definition of "success" as > or =20% peak IOP reduction, success rates for SLT1 and SLT2 were not significantly different. There was also no significant difference in eyes that received SLT2 6 to 12 months after SLT1 compared with those that received SLT2 12 months or more after SLT1.

CONCLUSIONS

Our findings suggest that repeat 360-degree SLT may be safe and effective after an initially successful 360-degree SLT has failed. These results may be achieved as early as 6 months after the first treatment.

摘要

目的

评估重复360度选择性激光小梁成形术(SLT)对既往成功接受过360度SLT的青光眼患者的疗效。

设计

回顾性病历审查。

方法

35例年龄≥18岁的开角型青光眼(原发性开角型、假性剥脱性或色素性青光眼)患者,在最大耐受药物治疗下眼压仍未得到控制,接受了首次360度SLT(SLT1),治疗成功维持≥6个月,但最终失效,随后接受了重复360度SLT(SLT2)。排除在研究期间之前或期间接受过氩激光小梁成形术或其他青光眼手术的患者。在每次手术前以及治疗后1至4周、1至3个月、5至8个月和首次SLT后15至21周记录眼压测量值。

结果

SLT1和SLT2后眼压降低在1至3个月重复治疗时显著减少,平均降低分别为-5.0和-2.9 mmHg(P = 0.01),但在其他等效时间点治疗之间无统计学显著差异。使用“成功”定义为眼压峰值降低≥20%,SLT1和SLT2的成功率无显著差异。与在SLT1后12个月或更长时间接受SLT2的患者相比,在SLT1后6至12个月接受SLT2的患者中也无显著差异。

结论

我们的研究结果表明,在最初成功的360度SLT失败后,重复360度SLT可能是安全有效的。这些结果最早可在首次治疗后6个月实现。

相似文献

1
Repeat selective laser trabeculoplasty.
J Glaucoma. 2009 Mar;18(3):180-3. doi: 10.1097/IJG.0b013e31817eee0b.
2
Selective Laser Trabeculoplasty: Outcomes of Multiple Repeat Treatments.
Ophthalmol Glaucoma. 2021 Sep-Oct;4(5):482-489. doi: 10.1016/j.ogla.2020.12.013. Epub 2021 Jan 9.
5
Repeatability of selective laser trabeculoplasty.
Br J Ophthalmol. 2016 Oct;100(10):1437-41. doi: 10.1136/bjophthalmol-2015-307486. Epub 2016 Feb 1.
6
Repeat selective laser trabeculoplasty can be effective in eyes with initial modest response.
Middle East Afr J Ophthalmol. 2014 Jul-Sep;21(3):205-9. doi: 10.4103/0974-9233.134668.
8
Efficacy of Repeat Selective Laser Trabeculoplasty in Medication-Naive Open-Angle Glaucoma and Ocular Hypertension during the LiGHT Trial.
Ophthalmology. 2020 Apr;127(4):467-476. doi: 10.1016/j.ophtha.2019.10.023. Epub 2019 Oct 30.
9
Intraocular pressure reduction after initial failure of selective laser trabeculoplasty (SLT).
Graefes Arch Clin Exp Ophthalmol. 2014 Feb;252(2):315-20. doi: 10.1007/s00417-013-2522-1. Epub 2013 Nov 21.
10
Selective laser trabeculoplasty in exfoliative glaucoma eyes with prior argon laser trabeculoplasty.
Acta Ophthalmol. 2020 Feb;98(1):58-64. doi: 10.1111/aos.14136. Epub 2019 May 15.

引用本文的文献

2
An Emerging Multi-mechanism and Multi-modal Approach in Interventional Glaucoma Therapy.
Ophthalmol Ther. 2025 Jan;14(1):13-22. doi: 10.1007/s40123-024-01073-z. Epub 2024 Nov 30.
3
Devices and Treatments to Address Low Adherence in Glaucoma Patients: A Narrative Review.
J Clin Med. 2022 Dec 24;12(1):151. doi: 10.3390/jcm12010151.
4
A Review of Selective Laser Trabeculoplasty: "The Hype Is Real".
J Clin Med. 2022 Jul 4;11(13):3879. doi: 10.3390/jcm11133879.
5
Peripheral anterior synechiae after selective laser trabeculoplasty among Chinese patients.
Graefes Arch Clin Exp Ophthalmol. 2022 Nov;260(11):3577-3585. doi: 10.1007/s00417-022-05685-8. Epub 2022 May 7.
6
Outcomes of initial and repeat micro-pulse transscleral cyclophotocoagulation in adult glaucoma patients.
Ther Adv Ophthalmol. 2022 Feb 14;14:25158414211064433. doi: 10.1177/25158414211064433. eCollection 2022 Jan-Dec.
7
Repeat Selective Laser Trabeculoplasty for Glaucoma Patients: A Systematic Review and Meta-analysis.
J Curr Glaucoma Pract. 2021 Sep-Dec;15(3):117-124. doi: 10.5005/jp-journals-10078-1302.
9
Selective Laser Trabeculoplasty Versus MIGS: Forgotten Art or First-Step Procedure in Selected Patients with Open-Angle Glaucoma.
Ophthalmol Ther. 2021 Sep;10(3):509-524. doi: 10.1007/s40123-021-00347-0. Epub 2021 May 7.

本文引用的文献

4
Selective targeting of trabecular meshwork cells: in vitro studies of pulsed and CW laser interactions.
Exp Eye Res. 1995 Apr;60(4):359-71. doi: 10.1016/s0014-4835(05)80093-4.
6
Retreatment with argon laser trabeculoplasty.
Ophthalmology. 1987 Sep;94(9):1085-9. doi: 10.1016/s0161-6420(87)33319-6.
7
Therapeutic limitations of argon laser trabeculoplasty.
Br J Ophthalmol. 1988 Apr;72(4):263-9. doi: 10.1136/bjo.72.4.263.
8
The effect of repeat argon laser trabeculoplasty.
Am J Ophthalmol. 1988 Dec 15;106(6):682-5. doi: 10.1016/0002-9394(88)90700-3.
9
Laser trabeculoplasty retreatment.
Ophthalmic Surg. 1989 Oct;20(10):702-6.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验